Wellington Management Group
PHAS

Wellington Management Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Wellington Management Group’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,674,690
Closed -$2.21M – 2239
2022
Q1 		$2.21M Sell
1,674,690
-1,194,960
-42% -$1.94M ﹤0.01% 1575
2021
Q4 		$7.49M Sell
2,869,650
-1,155,008
-29% -$3.49M ﹤0.01% 1346
2021
Q3 		$12.5M Sell
4,024,658
-515,239
-11% -$1.72M ﹤0.01% 1207
2021
Q2 		$16.9M Sell
4,539,897
-233,021
-5% -$776K ﹤0.01% 1130
2021
Q1 		$16.5M Buy
4,772,918
+3,205,262
+204% +$13M ﹤0.01% 1114
2020
Q4 		$5.27M Sell
1,567,656
-1,761,606
-53% -$6.31M ﹤0.01% 1315
2020
Q3 		$11.7M Sell
3,329,262
-686,967
-17% -$2.77M ﹤0.01% 1064
2020
Q2 		$18.5M Sell
4,016,229
-11,055
-0.3% -$49K ﹤0.01% 943
2020
Q1 		$13.3M Buy
4,027,284
+135,028
+3% +$618K ﹤0.01% 974
2019
Q4 		$23.8M Sell
3,892,256
-20,471
-0.5% -$84.3K 0.01% 940
2019
Q3 		$16.3M Buy
3,912,727
+17,514
+0.4% +$140K ﹤0.01% 1023
2019
Q2 		$51.1M Buy
3,895,213
+465,434
+14% +$5.7M 0.01% 749
2019
Q1 		$32.6M Buy
3,429,779
+58,819
+2% +$233K 0.01% 873
2018
Q4 		$10.4M Buy
+3,370,960
New +$13.4M ﹤0.01% 1172

Other funds holding PHAS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Wellington Management Group's PHAS Position: Q2 2022 in Review

Wellington Management Group sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q2 2022, closing a stake of 1,674,690 shares — an estimated $2.21M sold.

Wellington Management Group first reported a position in PHAS in Q4 2018 and held it in 14 quarters. The position peaked at $51.1M in Q2 2019. 49 funds tracked by Wall St. Rank hold PHAS as of Q2 2022.

  • Wellington Management Group reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Wellington Management Group sold 1,674,690 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $2.21M.
  • Wellington Management Group first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • Wellington Management Group's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $51.1M in Q2 2019.
  • 49 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.